Scinai Immunotherapeutics (SCNI) Investment Income (2023 - 2024)
Scinai Immunotherapeutics (SCNI) reported Investment Income of $10.5 million for Q3 2024, up 436.5% on a YoY basis from $1.9 million in Q4 2023, and up 436.5% sequentially from -$3.1 million in Q3 2023.
Scinai Immunotherapeutics (SCNI) Investment Income (2023 - 2024) Analysis & Trends
Scinai Immunotherapeutics (SCNI) has 2 years of Investment Income data on file, last reported at $10.5 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inv. Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Scinai Immunotherapeutics | 3.74 Bn | 624.08 Mn | -1.12 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 10.46 Mn |
| Sep 30, 2023 | -3.11 Mn |